Al Hawkins
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$2.2MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $2.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 30, 2026 | NIH | STTR Phase II Novel Adipose Targeted Gene Therapy for Lipodystrophy | $957K | ZVELT THERAPEUTICS INC. |
| Sep 9, 2025 | NIH | STTR Phase II Novel Adipose Targeted Gene Therapy for Lipodystrophy | $975K | ZVELT THERAPEUTICS INC. |
| Sep 15, 2023 | NIH | STTR Phase I Novel Adipose Targeted Gene Therapy for Lipodystrophy | $294K | ZVELT THERAPEUTICS INC. with OHIO STATE UNIVERSITY |
Peer ranks
Federal funding#894
Awards as PI#822
Patents#273
Companies
- ZVELT THERAPEUTICS INC.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.